Identifying Risk Factors for Diabetic Ketoacidosis Associated with SGLT2 Inhibitors: a Nationwide Cohort Study in the USA
Sign Up to like & getrecommendations! Published in 2021 at "Journal of General Internal Medicine"
DOI: 10.1007/s11606-020-06561-z
Abstract: Sodium glucose co-transporter-2 inhibitors (SGLT2) are commonly prescribed to patients with type 2 diabetes mellitus, but can increase the risk of diabetic ketoacidosis. Identifying patients prone to diabetic ketoacidosis may help mitigate this risk. We… read more here.
Keywords: risk; use; ketoacidosis; boosted trees ... See more keywords